Named Executive Officers — FY2025
Compensation Analysis
Computed directly from SEC-sourced figures tracked on this page — not a general description.
Zimmer Biomet Holdings discloses FY2025 compensation for 5 named executive officers, totaling $40.5M. Ivan Tornos, the Chief Executive Officer, accounts for 40% of that combined total.
Ivan Tornos's total compensation rose 7% year-over-year, from $15.0M in FY2024 to $16.1M in FY2025.
Cash compensation (salary plus bonus) made up 13% of Zimmer Biomet Holdings's FY2025 tracked executive pay, with stock awards accounting for 70%. That's notably more stock-weighted than the typical Healthcare company in this dataset, where stock awards average 0% of tracked pay.
Among 78 other Healthcare companies in this dataset, Zimmer Biomet Holdings's combined tracked executive pay of $40.5M ranks in the 87th percentile (industry median: $12.5M). Its highest-paid executive, Ivan Tornos, ranks in the 76th percentile for top-executive pay in the sector (industry median: $6.0M).
Compensation figures on this page for Zimmer Biomet Holdings come directly from its SEC DEF 14A proxy statement(s), filed with the SEC via EDGAR — not from crowdsourced or self-reported salary data.